- Global billion-dollar market projected to see steady growth in coming years
- Technological advancements expected to contribute to market growth
- Mediscan software transforms traditional 2D grayscale images into digital 3D high-definition images readily accessible to healthcare providers.
The United States medical imaging market size in 2020 valued at US$134 billion (
https://ibn.fm/1oQo2),
HYB Holding (OTC: HYBG) is looking to its two-month-old acquisition, Mediscan Inc., to bring significant value to the table. Acquired in November 2020 through a reverse acquisition transaction, Mediscan is a cloud-based software technology used in ultrasound that reconstructs the traditional analog two-dimensional (2D) grayscale visual image into a digital three-dimensional (3D), high-definition quantifiable format.
“Major factors driving the [global medical imaging] industry are increasing demand for early-stage diagnosis of chronic disease and rising aging demographics, which is expected to boost the demand for diagnostic imaging across the globe,” stated the Grand View Research report. “Technological advancements, coupled with supportive investments and funds by the government, especially in developing countries, such as India and China, are also expected to contribute to market growth.”
Technological advancement is what HYB is bringing to the space. With standard ultrasound 2D greyscale images as the norm and 3D imaging often requiring the use of CT, PET, MRI or X-ray technology, Mediscan’s innovative application could have a measurable impact on the medical imaging industry. The technology is designed to meet the need for imaging equipment and devices that can generate human anatomy data in 3D.
Through the Mediscan software, an ultrasound analog 2D grayscale image is transformed into a digital 3D HD format in under a minute. When paired with a portable ultrasound machine, Mediscan has the ability to produce scans that can be read on laptop computers, tablets and even smartphones by on-the-scene medical professionals including primary care physicians, specialists and technical support staff, as well as sports trainers, emergency medical services (“EMS”) personnel, and technicians in isolation wards and emergency rooms. The software requires only an internet connection and can generate 3D medical images of different organs, such as the heart, lungs, tendons, skin and nerves.
The impressive growth of the global market for diagnostic imaging creates a promising opportunity for HYB — and for potential investors. HYB is hoping to ride the tide of growth as the company focuses on the growth and development of Mediscan, which already has two patents pending.
The innovative software technology is designed to dramatically increase the ability of healthcare providers to use existing ultrasound devices at the point of care to identify meaningful data-driven clinical evaluations of a patient’s condition, whether in long-term, acute or emergency care situations. The software, which integrates with all popular EMR systems, also provides support for treatment options, monitors the patient’s ongoing progress or regress, and documents compliance with required protocols and procedures.
For more information, visit the company’s website at
www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HYBG are available in the company’s newsroom at
https://ibn.fm/HYBG
